Characterization of porcine tumor necrosis factor receptor 2: Implications for xenotransplantation

被引:5
|
作者
Costa, C.
Casinghino, S. R.
Fodor, W. L.
机构
[1] Hosp Llobregat, Hosp Duran & Reynals, Inst DInvest Biomed & Bellvitge IDIBELL, Barcelona 08907, Spain
[2] Alexion Pharmaceut Inc, Dept Mol Sci, Cheshire, CT USA
[3] Hosp Llobregat, Inst Invest Biomed & Bellvitge, Barcelona, Spain
[4] Univ Connecticut, Dept Mol & Cellular Biol, CT Ctr Regenerat Biol, Storrs, CT USA
关键词
D O I
10.1016/j.transproceed.2007.07.077
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clinical solid organ xenotransplantation is precluded by the strong immune response that results in rejection of pig xenografts in primate models. Innate immunity seems to play a major role in this process. In particular, tumor necrosis factor (TNF), produced by natural killer cells and macrophages, contributes to xenograft rejection by promoting endothelial cell activation and the recruitment of inflammatory cells. To further elucidate its molecular mechanism, we cloned the full-length cDNA of porcine TNF-Receptor 2 (pTNFR2, p75) by reverse transcriptase polymerase chain reaction (PCR) of total RNA isolated from porcine peripheral blood mononuclear cells. To this end, we used degenerate primers based on the sequences of the mouse, rat, and human homologues. Two PCR fragments were obtained that contained the pTNFR2 sequence, but differed in size. The shorter clones lacked the sequence corresponding to exon 4 by homology but identical for the rest, suggesting there is an alternative spliced mRNA variant of the porcine receptor. The predicted protein sequence (461 amino acids, containing exon 4) exhibited 72.5% identity to the human TNFR2 and 58.7% to the mouse molecule. By predicted protein sequence analysis, we determined that it comprised the four TNFR cysteine-rich repeats conserved between species. However, the molecule missing exon 4 lacks one cysteine-rich repeat. To assess function, we produced two recombinant proteins containing the extracellular domain of each pTNFR2 variant fused to the Fc portion of human IgG1. Next, we examined their ability to inhibit human TNF-mediated activation of porcine aortic endothelial cells. The addition of the whole pTNFR2 fusion protein to the TNF treatment blocked the up-regulation of activation markers. However, the fusion protein lacking exon 4 failed to effectively counteract TNF effects. These two pTNFR2 isoforms may play differential roles in the process of xenograft rejection.
引用
收藏
页码:2443 / 2446
页数:4
相关论文
共 50 条
  • [41] TUMOR-NECROSIS-FACTOR - CLINICAL IMPLICATIONS
    ROMIEU, M
    RICHE, F
    BOUSSEAU, A
    SZEKELI, B
    SCHURANDO, P
    BRIARD, C
    PAYEN, D
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1990, 9 (06): : 525 - 535
  • [42] The association of tumor necrosis factor α receptor 2 and tumor necrosis factor α with insulin resistance and the influence of adipose tissue biomarkers in humans
    Hivert, Marie-France
    Sullivan, Lisa M.
    Shrader, Peter
    Fox, Caroline S.
    Nathan, David M.
    D'Agostino, Ralph B., Sr.
    Wilson, Peter W. F.
    Benjamin, Emelia J.
    Meigs, James B.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (04): : 540 - 546
  • [44] CHARACTERIZATION OF A RECOMBINANT EXTRACELLULAR DOMAIN OF THE TYPE-1 TUMOR-NECROSIS-FACTOR RECEPTOR - EVIDENCE FOR TUMOR-NECROSIS-FACTOR-ALPHA INDUCED RECEPTOR AGGREGATION
    PENNICA, D
    KOHR, WJ
    FENDLY, BM
    SHIRE, SJ
    RAAB, HE
    BORCHARDT, PE
    LEWIS, M
    GOEDDEL, DV
    BIOCHEMISTRY, 1992, 31 (04) : 1134 - 1141
  • [45] Porcine PD-L1: cloning, characterization, and implications during xenotransplantation
    Jeon, Dae-Hyun
    Oh, Keunhee
    Oh, Byoung C.
    Nam, Dong H.
    Kim, Chi H.
    Park, Hyung-Bae
    Cho, Jaejin
    Lee, Jeong R.
    Lee, Dong-Sup
    Lee, Gene
    XENOTRANSPLANTATION, 2007, 14 (03) : 236 - 242
  • [46] Tumor necrosis factor α-induced osteoclastogenesis requires tumor necrosis factor receptor-associated factor 6
    Kaji, K
    Katogi, R
    Azuma, Y
    Naito, A
    Inoue, JI
    Kudo, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (09) : 1593 - 1599
  • [47] Moxibustion Treatment Restoring the Intestinal Epithelium Barrier in Rats with Crohn's Disease by Down-Regulating Tumor Necrosis Factor Alpha,Tumor Necrosis Factor Receptor 1,and Tumor Necrosis Factor Receptor 2
    施茵
    周恩华
    吴焕淦
    周次利
    王乾瑶
    戚莉
    Chinese Journal of Integrative Medicine, 2011, 17 (03) : 212 - 217
  • [48] Moxibustion treatment restoring the intestinal epithelium barrier in rats with Crohn's disease by down-regulating tumor necrosis factor alpha, tumor necrosis factor receptor 1, and tumor necrosis factor receptor 2
    Shi Yin
    Zhou En-hua
    Wu Huan-gan
    Zhou Ci-li
    Wang Qian-yao
    Qi Li
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2011, 17 (03) : 212 - 217
  • [49] Moxibustion treatment restoring the intestinal epithelium barrier in rats with Crohn’s disease by down-regulating tumor necrosis factor alpha, tumor necrosis factor receptor 1, and tumor necrosis factor receptor 2
    Yin Shi
    En-hua Zhou
    Huan-gan Wu
    Ci-li Zhou
    Qian-yao Wang
    Li Qi
    Chinese Journal of Integrative Medicine, 2011, 17 : 212 - 217
  • [50] The role of tumor necrosis factor receptor 2 (TNFR2) in EAE
    Arena, Maria Montes De Oca
    Bartsch, Brenden
    Schwegman, Lance
    Abdul-Baki, Nawal
    Forsthuber, Thomas
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):